0

Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 Billion by 2027—Allied Market Research

 
2022
Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market

Report Code : A03468

quote The global DTP vaccines market is expected to grow at a steady rate during the forecast period, owing to growth in awareness among people about the advantages of DTP vaccines globally, especially in developing countries. Moreover, rise in initiatives by pharma companies to enhance vaccine R&D is anticipated to supplement the DTP vaccines market growth. In addition, collaboration among the vaccine market stakeholders to employ combination of all available product development strategies is important to increase the overall success to make vaccination accessible across the globe. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major market share in the total DTP vaccine market in 2020. 

The key factors such as rise in demand for DTaP vaccine and growth in adoption of pertussis vaccine around the globe drives the growth of DTaP segment. Furthermore, high efficacy and rise in demand in developing regions is expected to drive the market during the forecast period. In addition, introduction of new combination of vaccines with DTaP further provides opportunities for the market players.
On the basis of age group segment, the pediatric segment is expected to grow at a significant CAGR of 4.9% during the forecast period, owing to increase in obese population worldwide. Vaccines for adults are likely to show high growth potential due to rise in incidences of infectious diseases among adults. In addition, growth in research and development and strong product pipeline is also likely to increase growth of the segment during the forecast period. 

By end user, in 2019, the hospitals segment dominated the DTP vaccines market, with large share due to faster availability of these vaccines in hospitals and shorter duration of procedure. Hospitals are the integral part of the healthcare sector, which act as the major source for revenue generation and aid in research and innovation.

Key Findings Of The Study 

  • DTaP is expected to be one of the most lucrative segments, registering a CAGR of 5.0% during the forecast period.

  • The Pediatric segment accounted for maximum share in the global DTP vaccines market in 2019, and is expected to grow at a CAGR of 4.9% during the forecast period. 

  • U.S. dominated the North America DTP Vaccine market, and is projected to retain this trend throughout the forecast period.

  • India is expected to exhibit the highest growth in the Asia-Pacific DTP Vaccine market, registering a CAGR of 6.6% during the forecast period.

  • South Africa is expected to witness the highest growth in the LAMEA DTP Vaccine market, growing at a CAGR of 5.5% during the forecast period.

In 2019, North America is expected to remain dominant during the forecast period due to high awareness and demand for DTaP vaccines and presence of major key players along with R&D laboratories. In addition, wide availability of advanced systems supplements the growth of the DTP vaccines market. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the increasing awareness in countries such as India and China. 

The key players operating in the global DTaP vaccine market are AJ Vaccines, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson, Massbiologics, Meiji Holdings Co., Ltd. (KM biologics co., Ltd.), Merck & Co., Inc., Panacea Biotec Ltd., Sanofi, and Serum Institute of India Pvt. Ltd..

 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market by Product Type (DTaP vaccine (Diphtheria-Tetanus-acellular Pertussis vaccine), TD (Tetanus and Diphtheria) vaccine, and Tdap (Tetanus-Diphtheria-Acellular Pertussis) vaccine, by Age Group (Adult and Pediatric), and by End User (Hospitals, Clinics, and Vaccination Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Mar 2024

Hairbrush Market

Download Sample
rep-img

Published Date Mar 2024

Debt Security Market

Download Sample
rep-img

Published Date Mar 2024

Wood Adhesives Market

Download Sample

Buy Full Version
"Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers